RheumNow Day 3 Recap ACR Convergence 2024 Highlights

Joining the discussion are Bella Mehta, a New York rheumatologist specializing in autoimmune diseases, Brian Jaros from Chicago, an expert in giant cell arteritis, and Quilin Conley from Galway, focusing on anti-obesity medications. They delve into new lupus nephritis recommendations and explore the interplay between psoriatic arthritis and immunotherapy mortality risks. Additionally, advancements in predicting vision loss in giant cell arteritis are discussed, alongside the potential of GLP-1 medications to benefit rheumatoid arthritis patients, despite challenges like side effects.